Scott D. Bercury

1.5k total citations
12 papers, 1.2k citations indexed

About

Scott D. Bercury is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Scott D. Bercury has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Scott D. Bercury's work include Lysosomal Storage Disorders Research (7 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Virus-based gene therapy research (2 papers). Scott D. Bercury is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Virus-based gene therapy research (2 papers). Scott D. Bercury collaborates with scholars based in United States and Netherlands. Scott D. Bercury's co-authors include Andrew M. Tager, Andrew D. Luster, Seng H. Cheng, Robin J. Ziegler, Robert E. Gerszten, Sabina A. Islam, Shannon K. Bromley, Benjamin D. Medoff, Erik B. Friedrich and Ronald K. Scheule and has published in prestigious journals such as The Journal of Experimental Medicine, Nature Immunology and PLoS ONE.

In The Last Decade

Scott D. Bercury

12 papers receiving 1.2k citations

Peers

Scott D. Bercury
Y. Cetin Germany
Masafumi Arima Japan
Magdalena M. Gorska United States
Hye Sun Kuehn United States
Pia Rantakari Finland
Bernard Gregory United Kingdom
David R. Gibb United States
Stefan Ries Germany
Gary Mallinson United Kingdom
Adi Sagiv Israel
Y. Cetin Germany
Scott D. Bercury
Citations per year, relative to Scott D. Bercury Scott D. Bercury (= 1×) peers Y. Cetin

Countries citing papers authored by Scott D. Bercury

Since Specialization
Citations

This map shows the geographic impact of Scott D. Bercury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Bercury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Bercury more than expected).

Fields of papers citing papers by Scott D. Bercury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Bercury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Bercury. The network helps show where Scott D. Bercury may publish in the future.

Co-authorship network of co-authors of Scott D. Bercury

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Bercury. A scholar is included among the top collaborators of Scott D. Bercury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Bercury. Scott D. Bercury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cabrera-Salazar, Mario A., Scott D. Bercury, Lingyun Li, et al.. (2012). Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease. PLoS ONE. 7(8). e43310–e43310. 64 indexed citations
2.
Ziegler, Robin J., Ernesto A. Salegio, James C. Dodge, et al.. (2011). Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Experimental Neurology. 231(2). 261–271. 23 indexed citations
3.
Ashe, Karen M., Dinesh S. Bangari, Lingyun Li, et al.. (2011). Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease. PLoS ONE. 6(6). e21758–e21758. 57 indexed citations
4.
Foley, Joseph W., Scott D. Bercury, Patrick F. Finn, et al.. (2010). Evaluation of Systemic Follistatin as an Adjuvant to Stimulate Muscle Repair and Improve Motor Function in Pompe Mice. Molecular Therapy. 18(9). 1584–1591. 14 indexed citations
5.
Hurlbut, Gregory D, Robin J. Ziegler, Jennifer B. Nietupski, et al.. (2010). Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy. Molecular Therapy. 18(11). 1983–1994. 117 indexed citations
6.
Cabrera-Salazar, Mario A., Scott D. Bercury, Robin J. Ziegler, et al.. (2010). Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease. Experimental Neurology. 225(2). 436–444. 24 indexed citations
7.
Zhu, Yunxiang, Nathan Gumlaw, Jinhua Zhang, et al.. (2009). Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease. Molecular Therapy. 17(6). 954–963. 133 indexed citations
8.
Ziegler, Robin J., Scott D. Bercury, Jonathan A. Fidler, et al.. (2008). Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe Mice. Human Gene Therapy. 19(6). 609–621. 50 indexed citations
9.
Ziegler, Robin J., Maribeth Cherry, Christine M. Barbon, et al.. (2006). Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8–mediated Hepatic Expression of α-galactosidase A. Molecular Therapy. 15(3). 492–500. 73 indexed citations
10.
Tager, Andrew M., Richard L. Kradin, Peter LaCamera, et al.. (2004). Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10. American Journal of Respiratory Cell and Molecular Biology. 31(4). 395–404. 164 indexed citations
11.
Tager, Andrew M., Shannon K. Bromley, Benjamin D. Medoff, et al.. (2003). Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nature Immunology. 4(10). 982–990. 335 indexed citations
12.
Tager, Andrew M., Jennifer Dufour, Katayoon Goodarzi, et al.. (2000). Bltr Mediates Leukotriene B4–Induced Chemotaxis and Adhesion and Plays a Dominant Role in Eosinophil Accumulation in a Murine Model of Peritonitis. The Journal of Experimental Medicine. 192(3). 439–446. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Cetin Breakdown of academic impact, for papers by Masafumi Arima Breakdown of academic impact, for papers by Magdalena M. Gorska Breakdown of academic impact, for papers by Hye Sun Kuehn Breakdown of academic impact, for papers by Pia Rantakari Breakdown of academic impact, for papers by Bernard Gregory Breakdown of academic impact, for papers by David R. Gibb Breakdown of academic impact, for papers by Stefan Ries Breakdown of academic impact, for papers by Gary Mallinson Breakdown of academic impact, for papers by Adi Sagiv
Rankless by CCL
2026